ITGAX and infection: A mouse study with rMVA-GFP demonstrated predominant infection of CD11c+ dendritic cells (DC) in the spleen at 9 hour post- administration (HPA), however, in this study rMVA-GFP was administered intravenously19, which is not a standard immunization route.